Colonoscopy
CRC screening trials exhibit ‘good adherence’ to guidelines, but improvements needed
Although adherence to standardized reporting guidelines ranged from 82.4% to 92.2% in published trials of colorectal cancer screening, researchers found that reporting of trial registration and informed consent materials could be improved.
‘Provider recommendation critical’ to colonoscopy uptake for non-Hispanic Black adults
WASHINGTON — Provider recommendation was a major influencer for colonoscopy screening for young adults at average risk for colorectal cancer, especially non-Hispanic Black patients, according to data presented at Digestive Disease Week.
Post-polypectomy surveillance colonoscopy associated with 77% reduction in CRC risk
WASHINGTON — Surveillance colonoscopy after polyp removal was associated with a 77% relative reduction in risk for colorectal cancer, although more research is needed to determine its effect on mortality risk, according to study results.
Follow-up colonoscopy for diverticulitis ‘unlikely to provide benefit’ beyond CRC screening
Most patients undergoing colonoscopy after diverticulitis had low risk for colorectal cancer, except those with complicated diverticulitis, whose risk was nearly four times greater than the screening population, according to research.
CRC incidence more than triples among children, teens from 1999 to 2020
Colorectal cancer incidence climbed 500% from 1999 to 2020 among children aged 10 to 14 years and 333% among adolescents aged 15 to 19 years, according to research presented at the Digestive Disease Week media briefing.
Are new colorectal cancer screening options a match for 'the gold standard'?
New testing options for colorectal cancer will likely expand access to screening, but they are not as reliable as a colonoscopy, according to experts.
Colonoscopy screening gap ‘could potentially be extended’ to 15 years for average-risk CRC
The 10-year interval between screening colonoscopies “could potentially be extended” to 15 years among patients without a family history of colorectal cancer and negative findings for CRC at the first colonoscopy, researchers reported.
Nearly 60 million individuals aged 45 to 85 years are eligible for CRC screening in the US
Researchers estimated that nearly 60 million individuals aged 45 to 85 years are at average-risk for colorectal cancer and eligible for screening in the U.S., according to cross-sectional study data in JAMA Network Open.
CRC rarely found in older adults at surveillance colonoscopy regardless of polyp history
Detection of colorectal cancer was “rare” at surveillance colonoscopy among patients aged 70 to 85 years, and although detection of advanced neoplasia was higher, overall yields did not increase significantly with age, researchers reported.
Blood-based CRC screening ‘less effective, more costly’ vs. recommended strategies
Triennial blood-based screening for colorectal cancer was not cost-effective compared with existing screening modalities such as colonoscopy, fecal immunochemical test and stool DNA testing, according to microsimulation model projections.